Company Presentation: Consumer Staples Bennett Cross, Ryan Darner, Feng Dong, Yichao Wang Agenda • Sector Overview • Company Analysis • • • • Wal-Mart Stores, Inc Philip Morris International, Inc Pepsico, Inc CVS Caremark Corporation • Recommendation Consumer Staples Sector Overview • Manufacturers and distributors of food, beverages and tobacco • Producers of non-durable household goods and personal products • Food & drug retail companies • Consumer supercenters Sector Overview • Comprises companies whose businesses are less sensitive to economic cycles • Defensive stocks • Buy – if economy declining • Sell – if economy improving • Typically pay high dividends Sector Overview Total Return 11.88% 5.86% Consumer Staples S&P 500 0.30% QTD -0.63% YTD S&P 500 vs. SIM Portfolio S&P 500 Allocation Telecom Svc 2.91% SIM Portfolio Allocation Telecom Svc 1.02% Utilities 3.50% Materials 3.45% Utilities 3.47% Materials 3.93% Consumer Discretionary 10.04% Consumer Discretionary 11.22% Consumer Staples 10.85% Information Technology 20.29% Consumer Staples 10.95% Information Technology 21.91% Energy 10.42% Energy 11.22% Industrials 7.37% Industrials 10.51% Health Care 11.39% Financials 14.68% Financials 13.36% Health Care 13.61% Sector Recommendation • Sell 60 basis points • SIM Portfolio is currently 10bps overweight in Consumer Staples sector relative to S&P 500 • Move to 50 bps underweight • Reasons • Consumer staples sector dramatically underperformed the S&P 500 during 1Q • Belief that economy will continue to recover 2Q and remainder of the year Stock Recommendation Recommended Current Wal-Mart WalMart 29% Phillip 33% CVS 38% sell 140 bps CVS hold Pepsi buy 140 bps Phillip Morris sell 60 bps Phillip 29% Pepsi 14% Wal-Mart 17% CVS 40% Wal-Mart Stores Inc. Company Overview Fourth largest in consumer staple sector $212.82B Market Cap $259.33B Enterprise Value ROE = 23.49% ROA = 8.82% Company Segments Wal-Mart U.S. • $264,186 million revenue • 2.58% growth rate Wal-Mart International • $125,873 million revenue • 8.76% growth rate Sam’s Club • $53,795 million revenue • 4.98% growth rate Sam's Club 7% Wal-Mart International 43% Walmart U.S. 50% Global Market UK 541 CANADA 333 CHINA 370 US 4,479 MEXICO 2,088 CHILE 316 AFRICA 347 INDIA 15 JAPAN 491 BRAZIL 512 AGENTINA 88 STORES WORLDWIDE 10,130 Stock Performance • One Year Range: $48.31 - $ 62.63 DCF Valuation Terminal Discount Rate 9.5% Terminal FCF Growth 2.3% NPV of Cash Flows $96,625 million NPV of terminal value $120,068 million Projected Equity Value $216,693 million Shares Outstanding 3,474 million Implied equity value/share $62.38 Multiples Valuation High Low P/Forward E 34.6 11.2 P/S 1.4 0.4 P/B 7.8 2.7 P/EBITDA 18.01 5.68 P/CF 27.5 7.9 Median Current Target Multiple 15.5 12.9 14 0.6 0.5 0.5 3.5 3 3 8.13 6.39 7.5 12 9.1 11 Target Price 70 68 66 63.75 60.5 75 73 Industry Target Multiple Target Price 71 COST TGT P/Forward E 20.1 12.9 13.9 15 75 69 P/S 0.4 0.5 0.3 0.5 68 67 P/B 2.9 2.3 3 3.1 68.2 P/EBITDA 10.58 4.9 4.22 7 59.5 P/CF 15 7.2 10.1 12 66 65 63 61 59 57 55 Historical Peer Companies Risks & Opportunities Risks • International Market faces challenge after Mexico bribe • Fast economic recovery will bring revenue away from Wal-Mart • Rise of strong competitors such as Amazon and EBay Opportunities • Growth of developing countries • Globalized supply chain Recommendation • DCF = $62.38/share • Multiple Valuation = $59.5/share - $70/share • Current Price = 62.43 • Sell 140 bps, but still keep around 60% for defense and diversification purpose Philip Morris International, Inc. Company Description • A U.S.-based international cigarette and tobacco company, strictly operating outside the U.S. • Diversified brand portfolio with the leading brand Marlboro • 28.1% share of international cigarette market excluding the U.S. and People’s Republic of China Stock Performance High Shareholder Return Dividend Available Cash 2008-2011 $3.08 Share Repurchase: +20.3% +10.3% $1.84 +17.4% +7.4% 21.4 Billion Dividend: Acquisition: 16.8billion 2.3 billion Cash Available 2008 Aug-08 Sep-09 Sep-10 2011 Business Segment 2011 Cigarette Shipment Volume 2011 Operating Income EU 11% 7.30% 23.10% EEMA 33.50% 35.50% ASIA 34.20% 31.70% LATIN AMERICA & CANADA 23.70% Asia: Major Value Driver • Larger population base with rapid growth rate • Relatively stable economic condition • Loose regulation 350000 313,282 Cigarette Volume • Outlook: • Organic volume growth 300000 Operating income 6000 5000 4,836 250000 4000 200000 3000 150000 2000 100000 1000 50000 0 0 2008 2009 2010 2011 EU: High Uncertainty • Declining demand • Current down trading • Highly regulated market 250000 Cigarette Volume Operating income 240000 4,560 230000 4800 4700 4600 4500 220000 4400 4300 210000 211,493 200000 4200 4100 190000 4000 2008 2009 2010 2011 • Outlook: • Short run: Declining demand • Long run: Declining demand, partially offsetting by price gain Regulation & Excise Taxes • • • • • Full and partial bans on smoking in public places Retail display bans Increase in minimum age to purchase Pictorial health warnings Continuous increase in Excise Taxes, partially offset by pricing power Risk & Opportunities Risks • Governmental excise tax increases, additional regulation • Falling demand & uncertain economy in EU, where Philip Morris generates 30% of its revenue • Performance hindered by a strengthening of the U.S. dollar. Opportunities • Addictive products enabling the firm to possess meaningful pricing power • With a focus on premium products, the firm has benefiting from consumers’ desires to trade up. • Growing in markets such as India, through population growth and market share gains. DCF Valuation NET REVENUE FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 EU -3.00% -2.50% -5.00% 6.12% -1.75% -5.67% EEMEA 2.00% 3.00% 4.00% 9.57% 14.88% -6.43% Asia 18.00% 23.00% 28.00% 28.59% 22.73% 1.56% Latin America & Canada 12.00% 13.00% 14.00% 12.19% 17.21% 14.46% Terminal Growth Rate Discount Rate 2.75% 9.25% Price from DCF:$90.61 Sensitivity Analysis Terminal Growth Rate Discount Rate $90.61 8.50% 8.75% 9.00% 9.25% 9.50% 9.75% 10.00% 10.25% 2.00% 96.211 92.515 89.085 85.894 82.918 80.135 77.528 75.081 2.25% 98.187 94.297 90.696 87.355 84.245 81.345 78.633 76.091 2.50% 100.327 96.221 92.431 88.924 85.668 82.638 79.811 77.167 2.75% 102.654 98.305 94.305 90.613 87.196 84.023 81.070 78.315 3.00% 105.192 100.571 96.334 92.438 88.841 85.511 82.420 79.542 3.25% 107.972 103.042 98.541 94.414 90.618 87.114 83.869 80.856 Multiples Valuation Relative to Industry High Low Median Current Relative to S&P 500 High Low Median Current P/Trailing E 1.4 0.8 1 1.3 P/Forward E 1.2 0.78 1 1.2 P/Trailing E 1.2 1 1.1 1.1 P/Forward E 1.1 0.99 1.1 1 P/B 4.7 0.8 1.8 NM P/B 28.4 2.7 7.7 NM P/S 1.3 0.5 0.6 1.3 P/S 3.8 1.2 1.5 3.8 P/CF 1.2 1 1.1 1 P/CF 1.8 1.1 1.5 1.7 Absolute Valuation High Low Median Current Target Multiple Target /Share Target Price P/ForwardE 16.7 11 13.7 16.6 17.4 5.39 93.8 P/S 4.8 1.1 1.6 4.8 1.9 48.46 92.1 P/EBITDA 11.79 6.24 9.48 10.92 10 9 90 P/CF 16.9 8.8 13.1 16 14.5 6 87 Final Price & Recommendation Target Price Weight P/Forward E 93.8 8% P/S 92.1 8% P/EBITDA 90 8% P/CF 87 8% DCF 90.61 68% Final Price Current Price: $84.74 7.0% upside Sell 60 bps 90.65 Pepsico, Inc Recommendation: Buy 140 basis points Business Overview Business Overview • Pepsico is the 2nd largest food and beverage producer in the world • Largest producer in the North American region • 19 Product lines Segment 2011 Net Sales 2012 Est. Net Sales 2014 Est. Net Sales Americas Foods $23,134 $23,597 $25,520 Americas Beverages $22,418 $22,866 $24,730 Europe $13,560 $13,831 $14,958 Asia, Middle East, Africa $7,392 $8,501 $11,833 Total $66,504 $68,795 $77,041 Stock Performance – 1 year Stock Performance – 5 years Multiples Valuation Multiples Valuation Average Target Price: $88.88 DCF Valuation DCF Valuation Target Price Valuation Weight Amount Discounted Cash Flow .4 $56.75 Ratio Analysis .6 $88.88 Target Price Current Price: $67.98 Downside Risk: -16.5% Upside Potential: 30.7% Margin of Safety on Target Price: 11.8% Recommendation: Buy 140 bps $75.98 Risks & Opportunities Risks • Shift towards “healthier” snacks could hurt FritoLay segment. • Continued growth in non-CSD segment (juice, tea, etc.) • Low adoption rates in expansion territories Opportunities • Success in current foreign expansion efforts. • Split from Frito-Lay segment. • Successful response to current domestic marketing efforts CVS Caremark Corp. Company Overview • Largest pharmacy health care provider in the United States • Retail Pharmacy Segment • Sells prescription drugs, over-the-counter drugs, general merchandise • MinuteClinic health care clinics • Pharmacy Benefit Management (PBM) • plan design and administration • formulary management • mail order pharmacy services Key Business Drivers • Large network of retail pharmacies • 7,200 pharmacy locations • ~ 75% of the U.S. population lives within 3 miles • Large pharmacy benefit network • Plan members have access to 64,000 retail pharmacies • Mail order pharmacy services • Prescriptions filled through mail service has increased for 3 of past 4 years • Lower cost to fill prescriptions Stock Performance DCF Valuation NET REVENUE 2014E 2013E 2012E 2011A 2010A 2009A Pharmacy Services $81,067 $77,206 $70,757 $58,874 $47,145 $50,551 % growth 5.0% 9.1% 20.2% 24.9% -6.7% 15.5% Retail Pharmacy $74,995 $71,423 $66,751 $59,599 $57,345 $55,355 % growth 5.0% 7.0% 12.0% 3.9% 3.6% 13.0% Terminal Growth Rate Discount Rate 3.0% 8.75% Current Price Implied Value Upside to DCF $44.43 $50.70 14.1% Multiples Valuation Relative to Industry High Low Median Current Relative to S&P 500 High Low Median Current P/Trailing E 1.1 .55 .89 1.1 P/Trailing E 1.5 .66 1.0 1.2 P/Forward E 1.0 .59 .89 1.0 P/Forward E 1.4 .71 .97 .99 P/B .9 .5 .8 .9 P/B 1.2 .5 .8 .7 P/S 1.1 .5 .8 1.1 P/S .6 .3 .4 .4 P/CF 1.1 .6 .9 1.1 P/CF 1.7 .8 1.2 1.2 Absolute Valuation High Low Median Current Target Multiple Target Price P/Forward E 22.0 9.6 16.0 13.4 16.5 $58.68 P/S 0.8 0.4 0.6 0.5 0.6 $55.13 P/B 3.7 1.0 2.3 1.0 1.5 $42.37 P/EBITDA 12.63 4.88 7.90 7.00 8.00 $61.67 P/CF 18.3 7.3 12.3 10.9 12.5 $61.68 Final Price & Recommendation Target Price Weight Multiples Valuation $51.40 20% DCF Valuation $50.43 80% Price Target $50.62 Current Price $44.88 Upside to Valuation 12.8% Recommendation: HOLD Risks & Opportunities Risks • Increasing market share of lower priced generic drugs • Potential slowdown in frontend sales due to a weak economic environment • Possibility of lower reimbursements by Medicaid and Medicare Opportunities • Walgreens leaving Express Scripts pharmacy network • Increasing use of mail order pharmacy services • Increase in prescription drug sales • Aging population • Expansion of health care coverage • Growth of MinuteClinic health care clinics Final Recommendation Wal-Mart sell 140 bps CVS hold Pepsi buy 140 bps Phillip Morris sell 60 bps Questions?